국가: 캐나다
언어: 프랑스어
출처: Health Canada
Bacitracine de zinc; Sulfate de polymyxine b; Néomycine (Sulfate de néomycine)
DECHRA LTD
400Unité; 10000Unité; 3.5MG
Pommade
Bacitracine de zinc 400Unité; Sulfate de polymyxine b 10000Unité; Néomycine (Sulfate de néomycine) 3.5MG
Ophtalmique
3.5G
Prescription
Chats; Chiens
Numéro de groupe d'ingrédients actifs (GIA) :0331380003
APPROUVÉ
2014-09-05
Dechra March 22, 2023 INNER LABEL – TUBE (3.5 g) Sterile / Stérile DIN 02431262 VETROPOLYCIN Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment, Mfr. Std. Onguent ophtalmique de sulfates de néomycine et de polymyxine B, et de bacitracine de zinc, Norme du fab. Veterinary Use Only / Usage vétérinaire seulement Antibiotic / Antibiotique 3.5 g DECHRA LTD. Dechra logo Cat and Dog picto CRIMP: Lot: Exp.: Dechra March 22, 2023 INSERT - ENGLISH DIN 02431262 VETROPOLYCIN Neomycin and Polymyxin B Sulfates and Bacitracin Zinc ophthalmic ointment, Mfr. Std. Veterinary Use Only Sterile ACTIVE INGREDIENTS Each g contains: bacitracin zinc 400 IU, neomycin sulfate 5 mg (equivalent to 3.5 mg neomycin base) and polymyxin B sulfate 10,000 IU. ACTIONS The three antibiotics present in Vetropolycin provide a broad spectrum of activity against the gram- positive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva. Bacitracin is effective against gram-positive bacteria including hemolytic and non-hemolytic streptococci and staphylococci. Resistant strains are rarely found. Neomycin is effective against both gram-positive and gram-negative bacteria including staphylococci, _Escherichia coli_, _Haemophilus _ _influenza_ and many strains of _Proteus_ and _Pseudomonas_. Polymyxin B is bactericidal to gram-negative bacteria especially _Pseudomonas_. No resistant strains have been found to develop _in vivo_. INDICATIONS For use in the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when caused by organisms susceptible to the antibiotics contained in this ointment. Laboratory tests should be conducted including _in vitro_ culturing and susceptibility tests on samples collected prior to treatment. DOSAGE AND ADMINISTRATION Care should be taken not to contaminate the applicator tip of the tube during administration. Do not allow the applicator tip to come into contact with any tissue. Apply a thin film over the cornea three 전체 문서 읽기